Global Increase in Antimicrobial Resistance, the next silent pandemic
Global Increase in Antimicrobial Resistance: The Next Silent Pandemic
DOI:
https://doi.org/10.26871/ceus.v6i3.258Abstract
La resistencia antimicrobiana (RAM) constituye una crisis global actual que amenaza la eficacia de los antibióticos y la sostenibilidad de la medicina moderna. Su expansión responde a factores estructurales, clínicos y sociales, agravados por el aumento del consumo de antibióticos, brechas en la vigilancia, sobreprescripción durante la pandemia de COVID-19 y debilidades regulatorias, especialmente en países de ingresos bajos y medios. La evidencia muestra un incremento sostenido de la mortalidad asociada a bacterias resistentes. Estrategias como los programas de stewardship, la vacunación, la innovación terapéutica y el acceso equitativo a antibióticos, diagnósticos y sistemas de vigilancia son esenciales para revertir esta tendencia.
Downloads
References
1. Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. https://pubmed.ncbi.nlm.nih.gov/35065702/
2. Naghavi M, Rezaei S, Ikuta K, et al. Global burden of antimicrobial resistance 1990–2021: a comprehensive analysis. Lancet. 2024;403(10431):2154–2178. https://pubmed.ncbi.nlm.nih.gov/38701543/
3. Gandra S, Barter D, Laxminarayan R. Antimicrobial resistance surveillance in low- and middle-income countries: progress and challenges. Clin Microbiol Rev. 2020;33(3):e00048-19. https://pubmed.ncbi.nlm.nih.gov/32522747/
5. Klein EY, Van Boeckel TP, Martinez EM, et al. Global trends in antibiotic consumption during 2016–2023. Proc Natl Acad Sci U S A. 2024;121(32):e2411919121. https://www.pnas.org/doi/10.1073/pnas.2411919121
associated infections. Clin Microbiol Infect. 2021;27(12):1772–1776. https://pubmed.ncbi.nlm.nih.gov/34111586/
6. O’Toole RF. The interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol Infect. 2021;27(12):1772–1776. https://pubmed.ncbi.nlm.nih.gov/34111586/
7. Granata G, Kaleci S, Ambrosi A, et al. Antibiotics use in COVID-19 patients: a systematic literature review. J Clin Med. 2022;11(23):7207. https://pubmed.ncbi.nlm.nih.gov/36498781/
8. Al Sulayyim HJ, Almasri A, Al-Qurayshi Z, et al. Antibiotic resistance during COVID-19: systematic review and meta-analysis. J Hosp Infect. 2022;125:1-11. https://pubmed.ncbi.nlm.nih.gov/36231256/
9. Ya KZ, Saito Y, Davison C, et al. Association between antimicrobial stewardship programmes and antibiotic use: systematic review and meta-analysis. J Antimicrob Chemother. 2023;78(10):2707-2716. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912134/
10. Iskandar K, Molinari N, Goff D, et al. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Lancet Infect Dis. 2021;21(9):e177–e188. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011122/
11. Sulis G, Adam M, Nafade V, et al. Antimicrobial resistance in low- and middle-income countries: a rapid systematic review of burden, drivers and response. BMJ Glob Health. 2022;7(6):e008832. https://pubmed.ncbi.nlm.nih.gov/34225545/
12. Tadesse BT, Kibuule D, Mboowa G, et al. Vaccination to reduce antimicrobial resistance burden: modelling evidence and perspectives. Clin Infect Dis. 2023;77(Suppl_7):S597–S606. https://academic.oup.com/cid/article/77/Supplement_7/S597/7481752
13. Frost I, Van Boeckel T, Laxminarayan R, et al. The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the clinical and development pipeline. Lancet Microbe. 2023;4(2):e113–e125. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00113-7/fulltext
14. Laxminarayan R, Impalli I, Rangarajan R, et al. Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance. Lancet. 2024;403(10443):2534-2550. doi:10.1016/S0140-6736(24)00878-X. https://pubmed.ncbi.nlm.nih.gov/38797178/
15. Sefah IA, Chetty S, Yamoah P, Bangalee V. The impact of antimicrobial stewardship interventions on appropriate use of surgical antimicrobial prophylaxis in low- and middle-income countries: a systematic review. Syst Rev. 2024;13:306. doi:10.1186/s13643-024-02731-w. https://pmc.ncbi.nlm.nih.gov/articles/PMC11657865/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 TAMARA CRISTINA MATUTE SANCHEZ
This work is licensed under a Creative Commons Attribution 4.0 International License.